SYNERGISTIC ANTITUMOR EFFECTS OF A COMBINED THERAPY CONSISTING OF IMMUNE CHECKPOINT INHIBITORS AND TUMOR-TARGETING NANOPARTICLES IN GLIOBLASTOMAM. Shevtsov,S. Stangl,B. Nikolaev, S. Edmond, L. Yakovleva,Y. Marchenko,V. Ryzhov,B. Margulis,E. Pitkin,G. MulthoffNeuro-oncology（2018）引用 0|浏览29暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
